BioCentury
ARTICLE | Clinical News

Neridronic acid regulatory update

December 21, 2016 12:41 AM UTC

Grünenthal said FDA granted breakthrough therapy designation to neridronic acid to treat complex regional pain syndrome (CRPS). The aminobisphosphonate is in Phase III testing and has Fast Track and O...